journal article·2023-04Open access

Hypoxia‐Induced FUS–circTBC1D14 Stress Granules Promote Autophagy in TNBC

Ying Liu, Yiwei Liu, Yinqiao He, Ning Zhang, Siyue Zhang, Yaming Li, Xiaolong Wang, Yiran Liang, Xi Chen, Weijing Zhao, Bing Chen, Lijuan Wang, Dan Luo, Qifeng Yang

Advanced Science· Volume 10· Issue 10

Abstract

Abstract Triple‐negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that is suggested to be associated with hypoxia. This study is the first to identify a novel circular RNA (circRNA), circTBC1D14, whose expression is significantly upregulated in TNBC. The authors confirm that high circTBC1D14 expression is associated with a poor prognosis in patients with breast cancer. circTBC1D14‐associated mass spectrometry and RNA‐binding protein‐related bioinformatics strategies indicate that FUS can interact with circTBC1D14, which can bind to the downstream flanking sequence of circTBC1D14 to induce cyclization. FUS is an essential biomarker associated with stress granules (SGs), and the authors find that hypoxic conditions can induce FUS–circTBC1D14‐associated SG formation in the cytoplasm after modification by protein PRMT1. Subsequently, circTBC1D14 increases the stability of PRMT1 by inhibiting its K48‐regulated polyubiquitination, leading to the upregulation of PRMT1 expression. In addition, FUS–circTBC1D14 SGs can initiate a cascade of SG‐linked proteins to recognize and control the elimination of SGs by recruiting LAMP1 and enhancing lysosome‐associated autophagy flux, thus contributing to the maintenance of cellular homeostasis and promoting tumor progression in TNBC. Overall, these findings reveal that circTBC1D14 is a potential prognostic indicator that can serve as a therapeutic target for TNBC treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Circular RNAs in diseases · RNA modifications and cancer · RNA Research and Splicing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Breast Surgery General Surgery Qilu Hospital of Shandong University Ji'nan Shandong 250012 P. R. China

Pathology Tissue Bank Qilu Hospital of Shandong University Ji'nan Shandong 250012 P. R. China

Research Institute of Breast Cancer Shandong University Ji'nan Shandong 250012 P. R. China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (59)

Show source-provided references
1. 10.3322/caac.2165410.3322/caac.21654 ↗
2. 10.1158/1055-9965.EPI-18-009810.1158/1055-9965.EPI-18-0098 ↗
3. 10.1158/1055-9965.EPI-20-103810.1158/1055-9965.EPI-20-1038 ↗
4. 10.3322/caac.2166010.3322/caac.21660 ↗
5. 10.1016/j.biomaterials.2020.12022710.1016/j.biomaterials.2020.120227 ↗
6. 10.1186/s12943-021-01444-110.1186/s12943-021-01444-1 ↗
7. 10.2217/epi-2018-014710.2217/epi-2018-0147 ↗
8. 10.1016/j.canlet.2022.21577810.1016/j.canlet.2022.215778 ↗
9. 10.1158/2159-8290.CD-21-137610.1158/2159-8290.CD-21-1376 ↗
10. 10.1016/j.ymthe.2021.08.02610.1016/j.ymthe.2021.08.026 ↗
11. 10.1038/s41418-021-00865-110.1038/s41418-021-00865-1 ↗
12. 10.1186/s12943-021-01375-x10.1186/s12943-021-01375-x ↗
13. 10.1038/cdd.2016.13310.1038/cdd.2016.133 ↗
14. 10.1186/s12943-022-01498-910.1186/s12943-022-01498-9 ↗
15. Liu Y. · Int J Oncol · 2018 · 53 · 1752
16. 10.1038/ncomms1474110.1038/ncomms14741 ↗
17. 10.1186/s12943-019-0959-510.1186/s12943-019-0959-5 ↗
18. 10.1083/jcb.20160908110.1083/jcb.201609081 ↗
19. 10.1016/j.molcel.2021.01.01610.1016/j.molcel.2021.01.016 ↗
20. 10.1016/j.tibs.2020.12.00510.1016/j.tibs.2020.12.005 ↗
21. 10.1016/j.cell.2020.12.02410.1016/j.cell.2020.12.024 ↗
22. 10.1038/s41589-021-00752-310.1038/s41589-021-00752-3 ↗
23. 10.1073/pnas.200243711710.1073/pnas.2002437117 ↗
24. 10.3390/cells712023210.3390/cells7120232 ↗
25. 10.1186/s12943-022-01570-410.1186/s12943-022-01570-4 ↗
26. 10.1038/nrm398210.1038/nrm3982 ↗
27. 10.1016/j.tibs.2017.09.00210.1016/j.tibs.2017.09.002 ↗
28. 10.3390/cancers1402030610.3390/cancers14020306 ↗
29. 10.3390/jpm1110100910.3390/jpm11101009 ↗
30. Vukovic V. · Cancer Res. · 2001 · 61 · 7394
31. 10.1038/s41419-020-02861-810.1038/s41419-020-02861-8 ↗
32. 10.1093/cvr/cvv12210.1093/cvr/cvv122 ↗
33. 10.1080/15548627.2022.210556210.1080/15548627.2022.2105562 ↗
34. 10.1038/s41467-017-02746-z10.1038/s41467-017-02746-z ↗
35. 10.1021/acs.accounts.9b0039710.1021/acs.accounts.9b00397 ↗
36. 10.1038/nrm252910.1038/nrm2529 ↗
37. 10.1038/s41467-018-05273-710.1038/s41467-018-05273-7 ↗
38. 10.1016/j.cell.2022.03.00510.1016/j.cell.2022.03.005 ↗
39. 10.1038/s41576-019-0158-710.1038/s41576-019-0158-7 ↗
40. 10.1016/j.ymthe.2019.05.01110.1016/j.ymthe.2019.05.011 ↗
41. 10.7150/thno.2410610.7150/thno.24106 ↗
42. 10.7150/ijbs.5891610.7150/ijbs.58916 ↗
43. 10.1016/j.omtn.2021.07.00310.1016/j.omtn.2021.07.003 ↗
44. 10.1186/s12943-021-01332-810.1186/s12943-021-01332-8 ↗
45. 10.1016/j.omtn.2021.09.01310.1016/j.omtn.2021.09.013 ↗
46. 10.1186/s13046-021-02063-w10.1186/s13046-021-02063-w ↗
47. 10.1038/s41388-021-01739-z10.1038/s41388-021-01739-z ↗
48. 10.1002/jcp.2948110.1002/jcp.29481 ↗
49. 10.1093/brain/awz21710.1093/brain/awz217 ↗
50. 10.1038/emboj.2012.26110.1038/emboj.2012.261 ↗
51. 10.1093/hmg/ddaa15910.1093/hmg/ddaa159 ↗
52. 10.1038/s41467-017-02299-110.1038/s41467-017-02299-1 ↗
53. 10.1212/NXI.000000000000070410.1212/NXI.0000000000000704 ↗
54. Choi S. · Exp. Mol. Med. · 2019 · 51 · 1
55. 10.1016/j.cell.2015.12.03810.1016/j.cell.2015.12.038 ↗
56. 10.1016/j.celrep.2022.11108610.1016/j.celrep.2022.111086 ↗
57. 10.1002/advs.20210381710.1002/advs.202103817 ↗
58. 10.1002/ijc.3378710.1002/ijc.33787 ↗
59. 10.1038/s41418-018-0217-110.1038/s41418-018-0217-1 ↗